Insulin stimulates nitric oxide synthesis in human platelets and, through nitric oxide, increases platelet concentrations of both guanosine-3', 5'-cyclic monophosphate and adenosine-3', 5'-cyclic monophosphate.
about
The prothrombotic tendency in metabolic syndrome: focus on the potential mechanisms involved in impaired haemostasis and fibrinolytic balanceObesity is associated with impaired platelet-inhibitory effect of acetylsalicylic acid in nondiabetic subjectsPotential Role of Protein Disulfide Isomerase in Metabolic Syndrome-Derived Platelet HyperactivityBeneficial effect of low ethanol intake on the cardiovascular system: possible biochemical mechanismsAdipocytokines in atherothrombosis: focus on platelets and vascular smooth muscle cells.Onion (Allium cepa L.) peel extract has anti-platelet effects in rat plateletsReduction of death rate due to acute myocardial infarction in subjects with cancers through systemic restoration of impaired nitric oxidePlatelet function in patients with diabetes mellitus: from a theoretical to a practical perspectiveHigh plasma 5-hydroxyindole-3-acetic acid concentrations in subjects with metabolic syndrome.High-risk type-2 diabetes mellitus patients, without prior ischemic events, have normal blood platelet functionality profiles: a cross-sectional study.Involvement of Nitric Oxide on Calcium Mobilization and Arachidonic Acid Pathway Activation during Platelet Aggregation with different aggregating agonistsTCF7L2 polymorphism is associated with low nitric oxide release, endothelial dysfunction and enhanced inflammatory response after myocardial infarction.Platelet perturbations in diabetes: implications for cardiovascular disease risk and treatment.Fructose-induced hypertension in Wistar-Kyoto rats: interaction with moderately high dietary salt.Is There a Role for Bioactive Lipids in the Pathobiology of Diabetes Mellitus?N-acetyl-L-cysteine exerts direct anti-aggregating effect on human platelets.Circulating heavy chain IgG, a pathological mediator for coronary artery disease, recognizes platelet surface receptors of both prostacyclin and insulin.IRS-1 mediates inhibition of Ca2+ mobilization by insulin via the inhibitory G-protein Gi.Dietary vitamin e supplementation attenuates hypertension in Dahl salt-sensitive rats.
P2860
Q27003277-267ED0C2-FA38-4B03-ACA7-0005DC841C0CQ28196731-6893F6C8-2DDA-4468-A44B-8E9B7ED3D1BBQ28354107-59ABD7E3-E519-4821-8A89-EFAA2239541BQ30360076-30D52F7F-CAC6-4C5C-9F21-A573D40DDE0AQ34002877-58E180DE-81C4-495D-A338-41BB455F4959Q35002507-95AA6C78-2B15-4D99-99CB-39FEBF9086B6Q35099613-8950880F-FAC8-4BC4-9F06-9B8BDF6D0C52Q35174193-260AFC4B-9DB1-467B-B1FC-14D7768338F4Q35620210-3532AF07-8255-4EF4-8D09-A3C665807A13Q35736714-EF5D6B07-C923-40A9-BBC0-2F0C4E46DB6CQ36828078-5979D154-CC17-4F39-97B2-B76016B087A3Q36897309-5B29DBF6-2B78-4BE4-A65E-4F688DFA6DD3Q37472064-C5DA4A16-28C7-4A5D-AEEF-F42675D729CCQ40197359-65BB270A-9225-4311-A845-C2C78431C1FDQ41205365-5E5F3878-9E31-47B6-8980-7D176850BC47Q43622945-5580A29C-C6ED-47FD-8870-80927AA730ECQ44506533-97F03374-C510-4395-B6AE-41E17CB1CDE1Q44645484-3A4DE225-975D-430D-9765-F8567EF9126EQ46555567-3831AFC6-008A-4051-97F9-0A80B065BD50
P2860
Insulin stimulates nitric oxide synthesis in human platelets and, through nitric oxide, increases platelet concentrations of both guanosine-3', 5'-cyclic monophosphate and adenosine-3', 5'-cyclic monophosphate.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Insulin stimulates nitric oxid ...... e-3', 5'-cyclic monophosphate.
@en
Insulin stimulates nitric oxid ...... e-3', 5'-cyclic monophosphate.
@nl
type
label
Insulin stimulates nitric oxid ...... e-3', 5'-cyclic monophosphate.
@en
Insulin stimulates nitric oxid ...... e-3', 5'-cyclic monophosphate.
@nl
prefLabel
Insulin stimulates nitric oxid ...... e-3', 5'-cyclic monophosphate.
@en
Insulin stimulates nitric oxid ...... e-3', 5'-cyclic monophosphate.
@nl
P2093
P356
P1433
P1476
Insulin stimulates nitric oxid ...... e-3', 5'-cyclic monophosphate.
@en
P2093
Costamagna C
Massucco P
Mattiello L
Mularoni E
P304
P356
10.2337/DIAB.46.5.742
P407
P577
1997-05-01T00:00:00Z